Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Quarterly Statistics: Private And Public Firms Were Prolific Fundraisers

Executive Summary

A review of biopharma start-up dealmaking and financing activity from April through June 2017, based on data from Strategic Transactions, showed that fundraising activity more than doubled compared with the first quarter.

Advertisement

Related Content

Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In
Takeda Picks Next Big Thing In Immunotherapy: Gamma Delta T Cells
Immune-Focused Discovery Firm Alpine Goes Public With Nivalis Merger
Novartis Hopes Lubris In-Licensing Deal Will Lead To Dry Eye Solution
Sucampo Looks To Add Heft With Vtesse Acquisition

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel